Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07839039Not yet recruiting
Randomised trial of ropivacaine and chloroprocaine in postoperative pain (2 arms), sponsored by Giorgio Veneziano. Primary endpoint: Postoperative pain score at 72 hours. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07839039.